4//SEC Filing
Epperly Corinne 4
Accession 0001415889-25-012291
CIK 0001740279other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:45 PM ET
Size
8.4 KB
Accession
0001415889-25-012291
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
Epperly Corinne
Director
Transactions
- Disposition to Issuer
Series B Warrants (right to buy)
2025-04-27−81,967→ 0 totalExercise: $1.50Exp: 2028-12-13→ Common Stock (81,967 underlying) - Award
Series B Warrants (right to buy)
2025-04-27+81,967→ 81,967 totalExercise: $0.45Exp: 2028-12-13→ Common Stock (81,967 underlying)
Footnotes (3)
- [F1]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.
- [F2]Fully vested and exercisable.
- [F3]The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
Documents
Issuer
IN8BIO, INC.
CIK 0001740279
Entity typeother
Related Parties
1- filerCIK 0001839156
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 8:45 PM ET
- Size
- 8.4 KB